Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Cataclysmically disseminating neurologic presentation in an immunosuppressed lupus patient: From the National Multiple Sclerosis Society Case Conference Proceedings.

Perrone CM, Lisak RP, Meltzer EI, Sguigna P, Tizazu E, Jacobs D, Melamed E, Lucas A, Freeman L, Pardo G, Goodman A, Fox EJ, Costello K, Parsons MS, Zamvil SS, Frohman EM, Frohman TC.

Neurol Neuroimmunol Neuroinflamm. 2019 Jun 13;6(4):e582. doi: 10.1212/NXI.0000000000000582. eCollection 2019 Jul. No abstract available.

2.

ACR Appropriateness Criteria® Ataxia.

Expert Panel on Neurologic Imaging:, Juliano AF, Policeni B, Agarwal V, Burns J, Bykowski J, Harvey HB, Hoang JK, Hunt CH, Kennedy TA, Moonis G, Pannell JS, Parsons MS, Powers WJ, Rosenow JM, Schroeder JW, Slavin K, Whitehead MT, Corey AS.

J Am Coll Radiol. 2019 May;16(5S):S44-S56. doi: 10.1016/j.jacr.2019.02.021.

PMID:
31054758
3.

ACR Appropriateness Criteria® Thyroid Disease.

Expert Panel on Neurological Imaging:, Hoang JK, Oldan JD, Mandel SJ, Policeni B, Agarwal V, Burns J, Bykowski J, Harvey HB, Juliano AF, Kennedy TA, Moonis G, Pannell JS, Parsons MS, Schroeder JW, Subramaniam RM, Whitehead MT, Corey AS.

J Am Coll Radiol. 2019 May;16(5S):S300-S314. doi: 10.1016/j.jacr.2019.02.004.

PMID:
31054756
4.

ACR Appropriateness Criteria® Neuroendocrine Imaging.

Expert Panel on Neurologic Imaging:, Burns J, Policeni B, Bykowski J, Dubey P, Germano IM, Jain V, Juliano AF, Moonis G, Parsons MS, Powers WJ, Rath TJ, Schroeder JW, Subramaniam RM, Taheri MR, Whitehead MT, Zander D, Corey A.

J Am Coll Radiol. 2019 May;16(5S):S161-S173. doi: 10.1016/j.jacr.2019.02.017.

PMID:
31054742
5.

Evaluating the Utility of a Postprocessing Algorithm for MRI Evaluation of Optic Neuritis.

Stunkel L, Sharma A, Parsons MS, Salter A, Van Stavern GP.

AJNR Am J Neuroradiol. 2019 Jun;40(6):1043-1048. doi: 10.3174/ajnr.A6057. Epub 2019 May 2.

PMID:
31048299
6.

Short Communication: Effect of Seminal Plasma on Functions of Monocytes and Granulocytes.

Selva KJ, Juno JA, Worley MJ, Chung AW, Tachedjian G, Kent SJ, Parsons MS.

AIDS Res Hum Retroviruses. 2019 Jun;35(6):553-556. doi: 10.1089/AID.2018.0219.

PMID:
31037950
7.

Image Processing to Improve Detection of Mesial Temporal Sclerosis in Adults.

Dahi F, Parsons MS, Orlowski HLP, Salter A, Dahiya S, Sharma A.

AJNR Am J Neuroradiol. 2019 May;40(5):798-801. doi: 10.3174/ajnr.A6022. Epub 2019 Apr 4.

PMID:
30948379
8.

Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of In Vitro versus In Vivo Models.

Juno JA, Wragg KM, Kristensen AB, Lee WS, Selva KJ, van der Sluis RM, Kelleher AD, Bavinton BR, Grulich AE, Lewin SR, Kent SJ, Parsons MS.

J Virol. 2019 May 15;93(11). pii: e00242-19. doi: 10.1128/JVI.00242-19. Print 2019 Jun 1.

PMID:
30867307
9.

CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.

Lee WS, Prévost J, Richard J, van der Sluis RM, Lewin SR, Pazgier M, Finzi A, Parsons MS, Kent SJ.

J Virol. 2019 May 1;93(10). pii: e01901-18. doi: 10.1128/JVI.01901-18. Print 2019 May 15.

PMID:
30842324
10.

Blunt Thoracolumbar-Spine Trauma Evaluation in the Emergency Department: A Meta-Analysis of Diagnostic Accuracy for History, Physical Examination, and Imaging.

VandenBerg J, Cullison K, Fowler SA, Parsons MS, McAndrew CM, Carpenter CR.

J Emerg Med. 2019 Feb;56(2):153-165. doi: 10.1016/j.jemermed.2018.10.032. Epub 2018 Dec 28. Review.

PMID:
30598296
11.

Influenza Virus Infection Enhances Antibody-Mediated NK Cell Functions via Type I Interferon-Dependent Pathways.

Jegaskanda S, Vanderven HA, Tan HX, Alcantara S, Wragg KM, Parsons MS, Chung AW, Juno JA, Kent SJ.

J Virol. 2019 Feb 19;93(5). pii: e02090-18. doi: 10.1128/JVI.02090-18. Print 2019 Mar 1.

12.

Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques.

Parsons MS, Lee WS, Kristensen AB, Amarasena T, Khoury G, Wheatley AK, Reynaldi A, Wines BD, Hogarth PM, Davenport MP, Kent SJ.

J Clin Invest. 2019 Jan 2;129(1):182-191. doi: 10.1172/JCI122466. Epub 2018 Nov 26.

13.

Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells.

Anand SP, Prévost J, Baril S, Richard J, Medjahed H, Chapleau JP, Tolbert WD, Kirk S, Smith AB 3rd, Wines BD, Kent SJ, Hogarth PM, Parsons MS, Pazgier M, Finzi A.

J Virol. 2019 Jan 17;93(3). pii: e01823-18. doi: 10.1128/JVI.01823-18. Print 2019 Feb 1.

14.

Enhancing contrast to noise ratio of hippocampi affected with mesial temporal sclerosis: A case-control study in children undergoing epilepsy surgeries.

Orlowski HLP, Smyth MD, Parsons MS, Dahiya S, Sharifai N, Hildebolt C, Sharma A.

Clin Neurol Neurosurg. 2018 Nov;174:144-148. doi: 10.1016/j.clineuro.2018.09.005. Epub 2018 Sep 5.

PMID:
30241008
15.

Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies.

Parsons MS, Chung AW, Kent SJ.

Retrovirology. 2018 Aug 22;15(1):58. doi: 10.1186/s12977-018-0438-x. Review.

16.

Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection.

Parsons MS, Le Grand R, Kent SJ.

Viruses. 2018 Jun 18;10(6). pii: E333. doi: 10.3390/v10060333. Review.

17.

Using Correlative Properties of Neighboring Pixels to Enhance Contrast-to-Noise Ratio of Abnormal Hippocampus in Patients With Intractable Epilepsy and Mesial Temporal Sclerosis.

Parsons MS, Sharma A, Hildebolt C.

Acad Radiol. 2019 Apr;26(4):e1-e8. doi: 10.1016/j.acra.2018.05.007. Epub 2018 Jun 12.

PMID:
29907398
18.

ACR Appropriateness Criteria® Orbits Vision and Visual Loss.

Expert Panel on Neurologic Imaging:, Kennedy TA, Corey AS, Policeni B, Agarwal V, Burns J, Harvey HB, Hoang J, Hunt CH, Juliano AF, Mack W, Moonis G, Murad GJA, Pannell JS, Parsons MS, Powers WJ, Schroeder JW, Setzen G, Whitehead MT, Bykowski J.

J Am Coll Radiol. 2018 May;15(5S):S116-S131. doi: 10.1016/j.jacr.2018.03.023.

PMID:
29724415
19.

Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses.

Richard J, Prévost J, Baxter AE, von Bredow B, Ding S, Medjahed H, Delgado GG, Brassard N, Stürzel CM, Kirchhoff F, Hahn BH, Parsons MS, Kaufmann DE, Evans DT, Finzi A.

MBio. 2018 Mar 20;9(2). pii: e00358-18. doi: 10.1128/mBio.00358-18.

20.

Contribution of NK Cell Education to both Direct and Anti-HIV-1 Antibody-Dependent NK Cell Functions.

Kristensen AB, Kent SJ, Parsons MS.

J Virol. 2018 May 14;92(11). pii: e02146-17. doi: 10.1128/JVI.02146-17. Print 2018 Jun 1.

21.

HIV Reactivation after Partial Protection by Neutralizing Antibodies.

Parsons MS, Cromer D, Davenport MP, Kent SJ.

Trends Immunol. 2018 May;39(5):359-366. doi: 10.1016/j.it.2017.12.006. Epub 2018 Jan 30. Review.

PMID:
29366547
22.

Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection.

Parsons MS, Lloyd SB, Lee WS, Kristensen AB, Amarasena T, Center RJ, Keele BF, Lifson JD, LaBranche CC, Montefiori D, Wines BD, Hogarth PM, Swiderek KM, Venturi V, Davenport MP, Kent SJ.

Sci Transl Med. 2017 Aug 9;9(402). pii: eaaf1483. doi: 10.1126/scitranslmed.aaf1483.

PMID:
28794282
23.

Fc functional antibodies in humans with severe H7N9 and seasonal influenza.

Vanderven HA, Liu L, Ana-Sosa-Batiz F, Nguyen TH, Wan Y, Wines B, Hogarth PM, Tilmanis D, Reynaldi A, Parsons MS, Hurt AC, Davenport MP, Kotsimbos T, Cheng AC, Kedzierska K, Zhang X, Xu J, Kent SJ.

JCI Insight. 2017 Jul 6;2(13). pii: 92750. doi: 10.1172/jci.insight.92750. eCollection 2017 Jul 6.

24.

Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.

Alsahafi N, Richard J, Prévost J, Coutu M, Brassard N, Parsons MS, Kaufmann DE, Brockman M, Finzi A.

J Virol. 2017 Jul 27;91(16). pii: e00109-17. doi: 10.1128/JVI.00109-17. Print 2017 Aug 15.

25.

Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption.

Lee WS, Kristensen AB, Rasmussen TA, Tolstrup M, Østergaard L, Søgaard OS, Wines BD, Hogarth PM, Reynaldi A, Davenport MP, Emery S, Amin J, Cooper DA, Kan VL, Fox J, Gruell H, Parsons MS, Kent SJ.

J Virol. 2017 Jul 12;91(15). pii: e00603-17. doi: 10.1128/JVI.00603-17. Print 2017 Aug 1.

26.

Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.

Madhavi V, Kulkarni A, Shete A, Lee WS, Mclean MR, Kristensen AB, Ghate M, Wines BD, Hogarth PM, Parsons MS, Kelleher A, Cooper DA, Amin J, Emery S, Thakar M, Kent SJ; ENCORE1 Study Group.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):345-353. doi: 10.1097/QAI.0000000000001380.

PMID:
28346319
27.

Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.

Prévost J, Zoubchenok D, Richard J, Veillette M, Pacheco B, Coutu M, Brassard N, Parsons MS, Ruxrungtham K, Bunupuradah T, Tovanabutra S, Hwang KK, Moody MA, Haynes BF, Bonsignori M, Sodroski J, Kaufmann DE, Shaw GM, Chenine AL, Finzi A.

J Virol. 2017 Mar 13;91(7). pii: e02452-16. doi: 10.1128/JVI.02452-16. Print 2017 Apr 1.

28.

Beyond Viral Neutralization.

Lewis GK, Pazgier M, Evans DT, Ferrari G, Bournazos S, Parsons MS, Bernard NF, Finzi A.

AIDS Res Hum Retroviruses. 2017 Aug;33(8):760-764. doi: 10.1089/AID.2016.0299. Epub 2017 Feb 16. Review.

29.

Cross-sectional Imaging Anatomy and Pathologic Conditions Affecting Thoracic Nerves.

Cummings KW, Sridhar S, Parsons MS, Javidan-Nejad C, Bhalla S.

Radiographics. 2017 Jan-Feb;37(1):73-92. doi: 10.1148/rg.2017160071. Epub 2016 Dec 2. Review.

PMID:
27911674
30.

Modulation of innate and adaptive cellular immunity relevant to HIV-1 vaccine design by seminal plasma.

Selva KJ, Kent SJ, Parsons MS.

AIDS. 2017 Jan 28;31(3):333-342. doi: 10.1097/QAD.0000000000001319.

PMID:
27835615
31.

NKG2D Acts as a Co-Receptor for Natural Killer Cell-Mediated Anti-HIV-1 Antibody-Dependent Cellular Cytotoxicity.

Parsons MS, Richard J, Lee WS, Vanderven H, Grant MD, Finzi A, Kent SJ.

AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1089-1096. Epub 2016 Sep 7.

PMID:
27487965
32.

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.

Vanderven HA, Ana-Sosa-Batiz F, Jegaskanda S, Rockman S, Laurie K, Barr I, Chen W, Wines B, Hogarth PM, Lambe T, Gilbert SC, Parsons MS, Kent SJ.

EBioMedicine. 2016 Jun;8:277-290. doi: 10.1016/j.ebiom.2016.04.029. Epub 2016 Apr 28.

33.

DC-SIGN and L-SIGN Are Attachment Factors That Promote Infection of Target Cells by Human Metapneumovirus in the Presence or Absence of Cellular Glycosaminoglycans.

Gillespie L, Gerstenberg K, Ana-Sosa-Batiz F, Parsons MS, Farrukee R, Krabbe M, Spann K, Brooks AG, Londrigan SL, Reading PC.

J Virol. 2016 Aug 12;90(17):7848-63. doi: 10.1128/JVI.00537-16. Print 2016 Sep 1.

34.

Decline of a Rare Moth at Its Last Known English Site: Causes and Lessons for Conservation.

Baker D, Barrett S, Beale CM, Crawford TJ, Ellis S, Gullett T, Mayhew PJ, Parsons MS, Relf P, Robertson P, Small J, Wainwright D.

PLoS One. 2016 Jun 22;11(6):e0157423. doi: 10.1371/journal.pone.0157423. eCollection 2016.

35.

The Significance of a Common Idiotype (1F7) on Antibodies against Human Immune Deficiency Virus Type 1 and Hepatitis C Virus.

Muller S, Parsons MS, Kohler H, Grant M.

Front Oncol. 2016 Feb 5;6:11. doi: 10.3389/fonc.2016.00011. eCollection 2016. Review.

36.

Brief Report: Seminal Plasma Anti-HIV Antibodies Trigger Antibody-dependent Cellular Cytotoxicity: Implications for HIV Transmission.

Parsons MS, Madhavi V, Ana-Sosa-Batiz F, Center RJ, Wilson KM, Bunupuradah T, Ruxrungtham K, Kent SJ.

J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):17-23. doi: 10.1097/QAI.0000000000000804.

PMID:
26761269
37.

Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.

Lee WS, Richard J, Lichtfuss M, Smith AB 3rd, Park J, Courter JR, Melillo BN, Sodroski JG, Kaufmann DE, Finzi A, Parsons MS, Kent SJ.

J Virol. 2015 Dec 9;90(4):2021-30. doi: 10.1128/JVI.02717-15. Print 2016 Feb 15.

38.

Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.

Gooneratne SL, Center RJ, Kent SJ, Parsons MS.

Clin Exp Immunol. 2016 Apr;184(1):101-9. doi: 10.1111/cei.12752. Epub 2016 Feb 4.

39.

Paradox of Protection: Preferential Recognition of CD4-induced Epitopes by Anti-HIV-1 ADCC Antibodies.

Parsons MS, Kent SJ.

EBioMedicine. 2015 Sep 30;2(10):1298-9. doi: 10.1016/j.ebiom.2015.09.048. eCollection 2015 Oct. No abstract available.

40.

λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein Antibodies.

Sajadi MM, Farshidpour M, Brown EP, Ouyang X, Seaman MS, Pazgier M, Ackerman ME, Robinson H, Tomaras G, Parsons MS, Charurat M, DeVico AL, Redfield RR, Lewis GK.

J Infect Dis. 2016 Jan 1;213(1):156-64. doi: 10.1093/infdis/jiv448. Epub 2015 Sep 7.

41.

Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses.

Veillette M, Richard J, Pazgier M, Lewis GK, Parsons MS, Finzi A.

Curr HIV Res. 2016;14(1):9-23.

PMID:
26310828
42.

Natural killer cell education does not affect the magnitude of granzyme B delivery to target cells by antibody-dependent cellular cytotoxicity.

Isitman G, Lisovsky I, Tremblay-McLean A, Parsons MS, Shoukry NH, Wainberg MA, Bruneau J, Bernard NF.

AIDS. 2015 Jul 31;29(12):1433-43. doi: 10.1097/QAD.0000000000000729.

PMID:
26244383
43.

Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?

Lee WS, Parsons MS, Kent SJ, Lichtfuss M.

Front Immunol. 2015 May 27;6:265. doi: 10.3389/fimmu.2015.00265. eCollection 2015. Review. No abstract available.

44.

Long-term changes to the frequency of occurrence of British moths are consistent with opposing and synergistic effects of climate and land-use changes.

Fox R, Oliver TH, Harrower C, Parsons MS, Thomas CD, Roy DB.

J Appl Ecol. 2014 Aug;51(4):949-957. Epub 2014 Apr 29.

45.

Location of core diagnostic information across various sequences in brain MRI and implications for efficiency of MRI scanner utilization.

Sharma A, Chatterjee A, Goyal M, Parsons MS, Bartel S.

AJR Am J Roentgenol. 2015 Apr;204(4):804-9. doi: 10.2214/AJR.14.13494.

PMID:
25794070
46.

Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.

Tang CC, Isitman G, Bruneau J, Tremblay C, Bernard NF, Kent SJ, Parsons MS.

Clin Exp Immunol. 2015 Aug;181(2):275-85. doi: 10.1111/cei.12593. Epub 2015 Jun 7.

47.

Role of education and differentiation in determining the potential of natural killer cells to respond to antibody-dependent stimulation.

Parsons MS, Loh L, Gooneratne S, Center RJ, Kent SJ.

AIDS. 2014 Nov 28;28(18):2781-6. doi: 10.1097/QAD.0000000000000489.

PMID:
25493604
48.

Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cells.

Gooneratne SL, Richard J, Lee WS, Finzi A, Kent SJ, Parsons MS.

J Virol. 2015 Jan;89(1):97-109. doi: 10.1128/JVI.02461-14. Epub 2014 Oct 15.

49.

Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy.

Madhavi V, Ana-Sosa-Batiz FE, Jegaskanda S, Center RJ, Winnall WR, Parsons MS, Ananworanich J, Cooper DA, Kelleher AD, Hsu D, Pett S, Stratov I, Kramski M, Kent SJ.

J Infect Dis. 2015 Feb 15;211(4):529-38. doi: 10.1093/infdis/jiu486. Epub 2014 Aug 28.

PMID:
25170105
50.

Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design.

Madhavi V, Wren LH, Center RJ, Gonelli C, Winnall WR, Parsons MS, Kramski M, Kent SJ, Stratov I.

AIDS. 2014 Aug 24;28(13):1859-70. doi: 10.1097/QAD.0000000000000310.

PMID:
24937308

Supplemental Content

Loading ...
Support Center